Copyright Reports & Markets. All rights reserved.

USA Finasteride Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Finasteride Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Type I Market Performance (Volume)
      • 2.1.2 Type II Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Type I Market Performance (Value)
      • 2.1.2 Type II Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Benign Prostatic Hyperplasia Market Performance (Volume)
      • 3.1.2 Male Pattern Baldness Market Performance (Volume)
      • 3.1.3 Other Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Merck
      • 4.1.1 Merck Profiles
      • 4.1.2 Merck Product Information
      • 4.1.3 Merck Finasteride Business Performance
      • 4.1.4 Merck Finasteride Business Development and Market Status
    • 4.2 Actavis
      • 4.2.1 Actavis Profiles
      • 4.2.2 Actavis Product Information
      • 4.2.3 Actavis Finasteride Business Performance
      • 4.2.4 Actavis Finasteride Business Development and Market Status
    • 4.3 Sandoz
      • 4.3.1 Sandoz Profiles
      • 4.3.2 Sandoz Product Information
      • 4.3.3 Sandoz Finasteride Business Performance
      • 4.3.4 Sandoz Finasteride Business Development and Market Status
    • 4.4 Teva Pharmaceuticals
      • 4.4.1 Teva Pharmaceuticals Profiles
      • 4.4.2 Teva Pharmaceuticals Product Information
      • 4.4.3 Teva Pharmaceuticals Finasteride Business Performance
      • 4.4.4 Teva Pharmaceuticals Finasteride Business Development and Market Status
    • 4.5 Cipla
      • 4.5.1 Cipla Profiles
      • 4.5.2 Cipla Product Information
      • 4.5.3 Cipla Finasteride Business Performance
      • 4.5.4 Cipla Finasteride Business Development and Market Status
    • 4.6 RelonChem
      • 4.6.1 RelonChem Profiles
      • 4.6.2 RelonChem Product Information
      • 4.6.3 RelonChem Finasteride Business Performance
      • 4.6.4 RelonChem Finasteride Business Development and Market Status
    • 4.7 Dr. Reddy
      • 4.7.1 Dr. Reddy Profiles
      • 4.7.2 Dr. Reddy Product Information
      • 4.7.3 Dr. Reddy Finasteride Business Performance
      • 4.7.4 Dr. Reddy Finasteride Business Development and Market Status
    • 4.8 Accord Pharmaceuticals
      • 4.8.1 Accord Pharmaceuticals Profiles
      • 4.8.2 Accord Pharmaceuticals Product Information
      • 4.8.3 Accord Pharmaceuticals Finasteride Business Performance
      • 4.8.4 Accord Pharmaceuticals Finasteride Business Development and Market Status
    • 4.9 Henan Topfond
      • 4.9.1 Henan Topfond Profiles
      • 4.9.2 Henan Topfond Product Information
      • 4.9.3 Henan Topfond Finasteride Business Performance
      • 4.9.4 Henan Topfond Finasteride Business Development and Market Status
    • 4.10 Zhejiang CONBA Pharmaceutical
      • 4.10.1 Zhejiang CONBA Pharmaceutical Profiles
      • 4.10.2 Zhejiang CONBA Pharmaceutical Product Information
      • 4.10.3 Zhejiang CONBA Pharmaceutical Finasteride Business Performance
      • 4.10.4 Zhejiang CONBA Pharmaceutical Finasteride Business Development and Market Status
    • 4.11 Shandong Renhetang Pharmaceutical
    • 4.12 Guangdong Eashu Pharmacetical

    5 Market Performance for Manufacturers

    • 5.1 USA Finasteride Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Finasteride Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Finasteride Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Finasteride Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Finasteride Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Finasteride Market Performance (Sales Point)

    • 7.1 USA Finasteride Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Finasteride Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Finasteride Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Finasteride Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Finasteride Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Benign Prostatic Hyperplasia Industry
    • 11.2 Male Pattern Baldness Industry
    • 11.3 Other Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Finasteride Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Finasteride Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Benign Prostatic Hyperplasia Sales and and Growth Rate 2019-2024
      • 12.4.3 Male Pattern Baldness Sales and and Growth Rate 2019-2024
      • 12.4.4 Other Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Finasteride Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Finasteride Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Finasteride for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Finasteride market competition by top manufacturers/players, with Finasteride sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck
    Actavis
    Sandoz
    Teva Pharmaceuticals
    Cipla
    RelonChem
    Dr. Reddy
    Accord Pharmaceuticals
    Henan Topfond
    Zhejiang CONBA Pharmaceutical
    Shandong Renhetang Pharmaceutical
    Guangdong Eashu Pharmacetical

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Type I
    Type II

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Finasteride for each application, including
    Benign Prostatic Hyperplasia
    Male Pattern Baldness
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now